Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 690

The DOI matches its Crossref record.

Doxorubicin cardiotoxicity: analysis of prevailing hypotheses

Olson, Richard D., Mushlin, Phillip S.·1990·The FASEB Journal

Abstract

Anthracyclines, such as doxorubicin and daunorubicin, are highly effective anticancer agents that produce a well‐described but incompletely understood cardiac toxicity. According to a popular hypothesis, anthracyclines injure the heart by generating oxygen‐centered free radicals. This free radical hypothesis, however, appears to be inconsistent with many observations, such as the frequent failure of anthracyclines at cardiotoxic doses to produce evidence of increased free radical generation. Other explanations of cardiotoxicity involve platelet‐activating factor, prostaglandins, histamine, calcium, and C‐13 hydroxy anthracycline metabolites. These C‐13 hydroxy metabolites, on the basis of in vitro data, are considerably more potent than parent compounds as myocardial depressants and as inhibitors of ATPases of sarcoplasmic reticulum, mitochondria, and sarcolemma. Further studies will be required to determine whether metabolites or the other putative injurious agents discussed contribute substantially to the cardiomyopathy of anthracycline therapy. The hypotheses presented in this paper should provide a useful framework for subsequent investigations into the mechanisms of anthracycline cardiotoxicity.— O lson , R. D.; M ushlin , P. S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4: 3076‐3086; 1990.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fasebj.4.13.2210154

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 690

Metadata

Authors
Olson, R. D., & Mushlin, P. S.
Venue
The FASEB Journal
Publisher
Wiley
Published
1990-10
Volume
4
Issue
13
Pages
3076-3086
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1791262955
Cited by
690
References
0
FWCI
13.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. https://app.cochat.ai/papers/10.1096/fasebj.4.13.2210154
The paper
Olson, R. D., & Mushlin, P. S. (1990). Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. The FASEB Journal. https://doi.org/10.1096/fasebj.4.13.2210154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.